ID   FH42
AC   CVCL_E627
AS   CVCL_F539
SY   ARA016; TER324; TER-324; Ter 324; TER383; TER-383; Ter 383; Extract 563
DR   dbMHC; 48817
DR   IHW; IHW09430
DR   IPD-IMGT/HLA; 10261
DR   Wikidata; Q54834830
RX   PubMed=30844424;
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/369cx.pdf
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Native North American; Tlingit.
CC   HLA typing: A*02,24; B*35,51; C*01:02,04:04; DPB1*04:02; DQA1*03:02,04:01; DQB1*03:03,04:02; DRB1*08:11,09:01; DRB4*01:03 (IPD-IMGT/HLA=10261).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
RX   PubMed=30844424; DOI=10.1016/j.humimm.2019.03.001; PMCID=PMC6599558;
RA   Creary L.E., Guerra S.G., Chong W., Brown C.J., Turner T.R.,
RA   Robinson J., Bultitude W.P., Mayor N.P., Marsh S.G.E., Saito K.,
RA   Lam K., Duke J.L., Mosbruger T.L., Ferriola D., Monos D.S., Willis A.,
RA   Askar M., Fischer G.F., Saw C.L., Ragoussis J., Petrek M.,
RA   Serra-Pages C., Juan Otero M., Stavropoulos-Giokas C., Dinou A., Ameen R.,
RA   Al Shemmari S., Spierings E., Gendzekhadze K., Morris G.P., Zhang Q.-H.,
RA   Kashi Z., Hsu S., Gangavarapu S., Mallempati K.C., Yamamoto F.,
RA   Osoegawa K., Vayntrub T., Chang C.-J., Hansen J.A.,
RA   Fernandez-Vina M.A.;
RT   "Next-generation HLA typing of 382 International Histocompatibility
RT   Working Group reference B-lymphoblastoid cell lines: report from the
RT   17th International HLA and Immunogenetics Workshop.";
RL   Hum. Immunol. 80:449-460(2019).
//